To study the efficacy of Pramehhara Kwatha in the management of Madhumeha w.s.r. to Type II Diabetes Mellitus

Not Applicable

• Conditions: Health Condition 1: E110- Type 2 diabetes mellitus with hyperosmolarity

• Registration Number: CTRI/2022/09/046025
• Lead Sponsor: Principal

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 17 October 2022

Recruitment & Eligibility

• Status: ot Yet Recruiting
• Sex: Not specified
• Target Recruitment: 0

Inclusion Criteria

Patients of type 2 diabetes mellitus having

a. Fasting Plasma Glucose -126 to 200 mg/dl

b. PPBS(2-hour Plasma Glucose Level) ââ?¬â?? 200 to 400 mg/dl

c. HbA1C between - 6.5% to 9%

Exclusion Criteria

Subjects suffering from the complications of diabetes mellitus i.e. Diabetic neuropathy, diabetic nephropathy, diabetic retinopathy etc. which require an urgent treatment.

Patients having major medical illness like cancer, concurrent infection like tuberculosis.

Patients with uncontrolled hypertension.

Patients with established diagnosis of CAD or any other clinically significant cardiovascular disease.

Renal dysfunction (defined by eGFR < 60ml/min calculated by MDRD calculator).

Subjects who have completed participation in any other clinical trial during the past 3 months.

Subjects with haemoglobin percentage < 9 gm% for males and < 8gm% for females.

Subjects with concurrent hepatic dysfunction (defined as AST and/or ALT >3 times of the upper normal limit)

Uncontrolled acute pulmonary dysfunction requiring inhalational or systemic steroids.

Pregnant/ lactating women.

Subjects on systemic or oral steroids, oral contraceptives pills or estrogen replacement therapy.

Study & Design

• Study Type: Interventional
• Study Design: Not specified